Non-Invasive Cryotherapy Device Market Global Report 2026

The non-invasive cryotherapy device market size has grown rapidly in recent years. It will grow from $0.24 billion in 2025 to $0.27 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing demand for non-invasive pain management therapies, rising adoption of cryotherapy in sports injury recovery, growing awareness of alternative rehabilitation treatments, expanding dermatology and aesthetic procedure applications, increasing availability of wellness and recovery centers.

The non-invasive cryotherapy device market size is expected to see rapid growth in the next few years. It will grow to $0.4 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to rising demand for portable cryotherapy devices in home care settings, increasing adoption of advanced cooling technologies, growing use of cryotherapy for preventive healthcare and wellness applications, expanding rehabilitation infrastructure worldwide, increasing investment in personalized recovery and therapeutic solutions. Major trends in the forecast period include increasing adoption of portable and handheld cryotherapy devices for convenient recovery and treatment, growing demand for non-invasive cold therapy solutions in pain management and rehabilitation, rising utilization of cryotherapy devices in sports medicine and athlete recovery programs, increasing preference for targeted localized cryotherapy treatments in dermatology and aesthetics, growing development of energy-efficient and temperature-controlled cryotherapy systems.

The rising sports injuries and growing demand for athletic recovery solutions are anticipated to drive the growth of the non-invasive cryotherapy device market in the coming years. Sports injuries and athletic recovery requirements refer to the increasing need for efficient treatment solutions that alleviate pain, speed up recovery, and enhance physical performance among athletes and physically active individuals. The growing occurrence of sports-related injuries is fueled by increased participation in sports activities, rising fitness consciousness, and greater involvement in high-intensity exercise and training programs. Non-invasive cryotherapy devices support recovery by minimizing pain, inflammation, and muscle discomfort while promoting tissue repair and enabling athletes to resume physical activities faster. For instance, in August 2025, according to Exercise & Sports Science Australia (ESSA), an Australia-based accreditation organization, around 62,000 Australians were hospitalized due to sports injuries during 2023-24. The report indicated that fractures represented over half of all sports injury-related hospitalizations (32,300 cases), while soft-tissue injuries, including sprains and strains, accounted for 18% (11,200 cases). Therefore, the increasing prevalence of sports injuries and the growing need for athletic recovery solutions are contributing to the expansion of the non-invasive cryotherapy device market.

Leading companies operating in the non-invasive cryotherapy devices market are focusing on developing advanced solutions, such as AI-enabled and IoT-integrated automated cryotherapy systems, to enhance equipment performance, enable predictive maintenance, and improve user experience. IoT-integrated automated cryotherapy systems are smart cold therapy devices that integrate connected sensors, cloud-based monitoring, and remote diagnostics to optimize system functionality. They support proactive maintenance, reduce downtime, and enhance operational reliability. For example, in May 2025, CryoPhit USA, a US-based manufacturer of electric cryotherapy systems, introduced an advanced automated cryotherapy solution featuring real-time monitoring, predictive diagnostics, remote access, and seamless integration with its HawkEye platform. The solution allows operators to remotely diagnose up to 80% of system issues, reducing downtime and improving operational efficiency. It also includes IoT connectivity and cloud-based monitoring capabilities to strengthen equipment reliability and enhance user experience.

In September 2024, MECOTEC GmbH, a Germany-based producer of electric cryotherapy chambers and cold air therapy equipment, acquired Zimno Tech (ZT) for an undisclosed value. This acquisition enhances MECOTEC’s presence in the non-invasive cryotherapy devices market by strengthening its electric cryotherapy chamber offerings, improving service capabilities, and expanding its footprint across the North American region. Zimno Tech (ZT) is a US-based developer and manufacturer of non-invasive cryotherapy solutions, specializing in electric whole-body cryotherapy chambers (cryochambers).

Major companies operating in the non-invasive cryotherapy device market report are Össur hf., Guangzhou Longest Science & Technology Co. Ltd., Metrum Cryoflex, Zimmer MedizinSysteme GmbH, MECOTEC GmbH, CryoBuilt Inc., Cryomed s.r.o., CRYO Science, Cryo Innovations, CRYONiQ LLC, JUKA Sp. z o.o., Artica Systems, Physiomed Elektromedizin AG, America Cryo, CTN (CryoTech Nordic Oy), MedStarCom.

North America was the dominant region in the non-invasive cryotherapy device market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the non-invasive cryotherapy device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-invasive cryotherapy device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.